ARTICLE
Volume 10,Issue 4
30 May 2022
Research Progress of Traditional Chinese and Western Medicine in Hyperthyroid Heart Disease
Shuyu Li ,
Mingjun Zhao
Show Less
1
Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China,
2
Affiliated Hospital Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China,
PAR 2022 , 6(3), 42–47;
https://doi.org/10.26689/par.v6i3.3984
© 2022 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
In recent years, hyperthyroid heart disease has become a condition with high incidence rate and high mortality rate. This paper discusses the pathogenesis, treatment, and influencing factors of hyperthyroid heart disease from two different angles – traditional Chinese medicine and western medicine – in hope to provide a reference basis for the treatment of hyperthyroid heart disease.
References
Poutasse CM, Herbstman JB, Peterson ME, et al., 2019, Silicone Pet Tags Associate Tris(1,3-dichloro-2-isopropyl) Phosphate Exposures with Feline Hyperthyroidism. Environ Sci Technol, 10(9): 23-24.
Sano M, Homma T, Ishige T, et al., 2017, An Autopsy Case of Hyperthyroid Cardiomyopathy Manifesting Lethal Congestive Heart Failure. Pathology International, 67(2): 110-112.
Qiang Z, Jin B, Lu Q, et al., 2019, Regulation of MicroRNA-146 in Hyperthyroid Heart Disease. Chinese Journal of Clinical Anatomy, 37(03): 273-277. DOI: 10.13418/j.issn.1001-165x.2019.03.007
Feng Y, 2020, Efficacy of Detection of cTnI, CK, CK-MB and NT-pro BNP Levels in the Diagnosis of Hyperthyroidism Heart Disease. Medical Journal of Chinese People’s Health, 32(24): 110-112.
Dillmann W, 2010, Cardiac Hypertrophy and Thyroid Hormone Signaling. Heart Fail Rev, 15(2): 125-132.
Hao X, Liu J, Cui Y, 2020, Analysis of Risk Factors of Hyperthyroidism Complicated with Hyperthyroid Heart Disease. Electronic Journal of Practical Gynecologic Endocrinology, 7(18): 151-152. DOI: 10.16484/j.cnki.issn2095-8803.2020.18.098
Wang W, Cheng Q, 2017, Analysis of Risk Factors of Hyperthyroidism Complicated with Hyperthyroid Heart Disease. Modern Instruments & Medical Treatment, 23(05): 43-44, 47.
Biondi B, Bartalena L, Cooper DS, et al., 2015, The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J, 4(3): 149-163.
Klein I, Danzi S, 2016, Thyroid Disease and the Heart. Curr Probl Cardiol, 41(2): 65-92.
Xiang Q, 2020, Effect of (131)-Iodine in the Treatment of Hyperthyroidism Heart Disease. Journal of Clinical Rational Drug Use, 13(23): 43-45. DOI: 10.15887/j.cnki.13-1389/r.2020.23.019
Huang LK, 2017, Clinical Analysis and Efficacy of 131I Iodine in the Treatment of Hyperthyroidism Heart Disease. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 5(26): 143-144. DOI: 10.16282/j.cnki.cn11-9336/r.2017.26.114
Tan X, 2020, (131) I Combined with Propranolol in the Treatment of Hyperthyroid Heart Disease. Medical Diet and Health, 18(20): 73, 76.
Ren Y, Ma J, Liu P, et al., 2020, Analysis of Risk Factors Associated with Hyperthyroidism of Heart Disease. Ningxia Medical Journal, 42(05): 406-408. DOI: 10.13621/j.1001-5949.2020.05.0406
Zhou Y, Zhang Z, 2017, Etiology and Pathogenesis of Hyperthyroidism. Henan Traditional Chinese Medicine, 37(10): 1771-1773.
Zhao X, Jiang Z, Fan G, 2019, Clinical Study and Analysis of Hyperthyroidism Heart Disease. Clinical Journal of Chinese Medicine, 11(25): 53-55.
Xing Y, Li Z, Zhou Y, et al., 2020, Li Zhongnan’s Experience in Treating Hyperthyroid Heart Disease. Henan Traditional Chinese Medicine, 40(08): 1200-1203. DOI: 10.16367/j.issn.1003-5028.2020.08.0304
Zhong X, Wang Y, 2019, Observation on the Efficacy of Self-Made Jianpi Jieyu Prescription Assisted by Symptomatic Intervention of Western Medicine in the Treatment of Heart Disease Secondary to Hyperthyroidism. Journal of Emergency in Traditional Chinese Medicine, 28(11): 2032-2034.
Pan J, Zhang J, Li Y, et al., 2017, Clinical Study of Shugan Yiqi Yangying Decoction in the Treatment of Hyperthyroid Heart Disease. Journal of Emergency in Traditional Chinese Medicine, 26(07): 1278-1280.
Du G, 2017, Treatment of 41 Cases of Hyperthyroidism Heart Disease with Xiaoyao Powder. China’s Naturopathy, 25(07): 57-58. DOI: 10.19621/j.cnki.11-3555/r.2017.07.045
Wang Q, 2018, Clinical Efficacy and Safety of Traditional Chinese Patent Medicine for Hyperthyroid Heart Disease: Study Protocol for A Systematic Review and Meta-Analysis. Medicine (Baltimore), 97(45): e13076. DOI: 10.1097/MD.0000000000013076
Yu Q, Song Z, 2016, Saizhi Combined with Danzhi Xiaoyao Powder in the Treatment of Hyperthyroid Heart Disease. Nei Mongol Journal of Traditional Chinese Medicine, 35(16): 22. DOI: 10.16040/j.cnki.cn15-1101.2016.16.025
Zhang Z, 2016, Analysis of Curative Effect of Shengmaiyin Combined with Western Medicine in Treating Hyperthyroidism Heart Disease. Cardiovascular Disease Journal of integrated traditional Chinese and Western Medicine, 4(16): 193-194. DOI: 10.16282/j.cnki.cn11-9336/r.2016.16.140
Wang Z, Wang X, Yang Y, et al., 2018, Clinical Observation of Anshendingzhao Pill in the Treatment of 86 Cases of Hyperthyroidism Heart Disease. World Latest Medical Information Abstracts, 18(12): 89, 97. DOI: 10.19613/j.cnki.1671-3141.2018.12.060
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia